Popular Articles
Revitol Cellulite Cream

CEL-SCI Developing Immune-Based Treatment Against Swine And Other H1N1 Flu Viruses Using Proprietary L.E.A.P.S. Technology
CEL-SCI Corporation (NYSE AMEX: CVM) announced that it is developing an immune-based treatment for the "swine flu and related H1N1" flu viruses, utilizing its proprietary L.E.A.P.S.(TM) (Ligand Epitope Antigen Presentation System) vaccine technology. The Company plans to utilize the expertise and knowledge it has gained from developing protective and therapeutic vaccines utilizing L.E.A.P.S. to develop a therapeutic treatment based upon the technology for people infected with the swine and H1N1 flu viruses. CEL-SCI has already commenced pre-clinical testing. Don't forget to buy zoloft online no prescription.

Eurand Successfully Completes Registration Procedure For Paracetamol ODT 250 And 500 Mg In The European Union
Eurand N.V. (NASDAQ: EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies, announced that the Dutch Medicines Evaluation Board (MEB) informed the Company that the Decentralized Procedure (DCP) for registration of Paracetamol 250 and 500 mg Orodispersible Tablets (ODT) in several EU countries has been successfully completed.

generic viagra online


News of the day
Nevada Assembly Passes Bill To Protect Physicians On J-1 Visas
The Nevada Assembly last week voted to approve a bill (SB 229) that would authorize the Nevada Department of Health and Human Services to stop the exploitation of foreign physicians who have come to the state to provide care to residents in underserved areas, the Las Vegas Sun reports. The measure now goes to Gov. Jim Gibbons (R) for his approval (Allen, Las Vegas Sun, 5/28). A September 2007 Sun investigation of the J-1 visa program found that some foreign physicians were forced by their sponsors to work up to 100 hours per week, and were being "cheated out of their salaries" and "diverted from the patients" in underserved areas whom they were supposed to help (Kaiser Daily Health Policy Report, 8/6/08).The legislation would make violations of the J-1 program more clearly punishable under state law and prosecutable by the attorney general"s office; charge J-1 physician sponsors a fee to cover the cost of enforcing the law; and protect whistle-blowers (Las Vegas Sun, 5/28).
Health Insurance

Developing Countries Need $1B By End Of Year To Cope With H1N1, U.N. Says

Developing countries will need an estimated $1 billion by year"s end to ensure their access to antivirals and vaccines to protect against the H1N1 (swine flu) virus, U.N. Secretary General Ban Ki-moon said Monday, AFP/Google.com reports. "Funding had "not been flowing as expected," following appeals in recent weeks, [Ban] added," according to the news service (7/6). During an address to government officials from donor countries Monday, Ban said he was counting on their support, according to the AP/Google.com. "Public funding should come first before we ask for any private fundings," he said. "Many of the developing countries have weak health systems," WHO Director-General Margaret Chan said. "They actually go into this pandemic what I call empty-handed. They don"t have antivirals. They don"t have vaccines. They don"t have antibiotics." Additionally, health officials worry "that people in poorer countries and those fighting other health problems like malaria, tuberculosis, malnutrition and pneumonia might be more susceptible to swine flu," according to AP/Google.com. "Chan told the donors that she wants to mobilize a minimum stockpile of vaccines to 49 of the world"s least developed countries" but did not name what countries would receive vaccines, according to the AP/Google.com (Engeler, 7/6). In related news, Reuters examines the toll of the H1N1 virus in Argentina, where citizens "are questioning the government"s handling of an H1N1 flu outbreak that has killed 60 people" - the third highest death toll in the world after Mexico and the U.S. The article details how confusion over the number of H1N1 cases reported, and the fact Argentina"s death toll has "more than doubled" in "less than a week," has led to public "accusations that officials acted too slowly" (Wroclavsky, 7/6). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):